PITTSBURGH (PA) MAY 24-26, 2018 - FINAL PROGRAM - JOINT MEETING - Sres Symposium
←
→
Transcription du contenu de la page
Si votre navigateur ne rend pas la page correctement, lisez s'il vous plaît le contenu de la page ci-dessous
JOINT MEETING
15th ANNUAL PITTSBURGH VASCULAR SYMPOSIUM
19th SURGICAL AND RADIOLOGICAL ENDOVASCULAR SYMPOSIUM
Crédit photo : Shutterstock®
FINAL PROGRAM
MAY 24-26, 2018
PITTSBURGH (PA)
www.sres-symposium.org
SYSTÈME DE FERMETURE ARTÉRIELLE
La sécurité d’une fermeture mécanique,
la sureté d’une fermeture extravasculaire.
Ballon semi-compliant Détail du Tube d’avancement (vue
après le déploiement du produit de
Extrémité scellement)
atraumatique
Manchon du produit Navette
de scellement
Poignée
Tube de la navette
HÉMOSTASE PRODUIT DE FERMETURE
TEMPORAIRE SCELLEMENT
EN PLACE
MYNXGRIP® est utilisé pour sceller les sites d’accès à l’artère fémorale et à la veine fémorale tout en réduisant le temps jusqu’à l’hémostase et jusqu’à la reprise de la marche chez les
patients ayant subi un cathétérisme diagnostique ou une intervention endovasculaire avec une gaine d’intervention de 5F, de 6F ou de 7F. Avant toute utilisation, se référer à la notice
d’utilisation qui accompagne le dispositif pour connaître les indications, les contre-indications, les effets secondaires, l’utilisation recommandée, les mises en garde et les précautions,
notamment le paragraphe portant sur les populations de patients particuliers, et respecter les consignes d’utilisation figurant dans la notice d’utilisation et sur l’étiquetage. Dans un souci
de constante amélioration de ses produits, Cordis se réserve le droit de modifier leurs caractéristiques sans préavis. Dispositif médical de classe III (BSI 0086). Mandataire Européen :
Emergo Europe (Pays-Bas). Le dispositif de fermeture vasculaire MYNXGRIP est pris en charge par l’assurance maladie au travers des Groupes Homogènes de Séjour. Mars 2017. EU2209
03/17. Document réservé à l’utilisation des professionnels de santé.
© 2017 Cardinal Health. Tous droits réservés. CORDIS, le logo CORDIS et MYNXGRIP sont des marques commerciales ou des marques déposées de Cardinal Health. Toutes les autres
marques appartiennent à leurs détenteurs respectifs. Le dispositif de fermeture vasculaire MYNXGRIP est fabriqué par Cardinal Health et fait partie du portefeuille Cordis. CORDIS une
division de CARDINAL HEALTH FRANCE 506 SAS, 43 rue Camille Desmoulins, 92130 Issy-les-Moulineaux. RCS Paris 812 365 609.
2
JOINT MEETING
15th ANNUAL PITTSBURGH VASCULAR SYMPOSIUM
MAY 24-26, 2018
19th SURGICAL AND RADIOLOGICAL ENDOVASCULAR SYMPOSIUM PITTSBURGH (PA)
COMMITTEES
ORGANIZING COMMITTEE
Efthymios Avgerinos, MD (Pittsburgh, PA, USA)
Jean-Michel Bartoli, MD (Marseille, France)
Rabih A. Chaer, MD, MSc (Pittsburgh, PA, USA)
Michael D. Dake, MD (Stanford, CA, USA)
Eric S. Hager, MD (Pittsburgh, PA, USA)
Steven A. Leers, MD, RVT, RPVI, FSVU (Pittsburgh, PA, USA)
Michel S. Makaroun, MD (Pittsburgh, PA, USA)
Philippe Piquet, MD (Marseille, France)
LOCAL ORGANIZING COMMITTEE
Georges Al-Khoury, MD (Pittsburgh, PA, USA)
Mohammad H. Eslami, MD (Pittsburgh, PA, USA)
Ulka Sachdev, MD (Pittsburgh, PA, USA)
Michael J. Singh, MD, FACS, RPVI (Pittsburgh, PA, USA)
Edith Tzeng, MD (Pittsburgh, PA, USA)
ORGANIZING COMMITTEE FOR FELLOWS
Pierre-Antoine Barral, MD (Marseille, France)
David Bensoussan, MD (Marseille, France)
Marine Gaudry, MD (Marseille, France)
Elizabeth Genovese, MD (Pittsburgh, PA, USA)
Nathan Liang, MD (Pittsburgh, PA, USA)
Virgile Omnes, MD (Marseille, France)
Gregory Salzler, MD (Pittsburgh, PA, USA)
Farouk Tradi, MD (Marseille, France)
Sung Yang, MD (Pittsburgh, PA, USA)
GENERAL ORGANIZATION
MCO Congrès - Villa Gaby - 285 Corniche Kennedy - F-13007 Marseille
Tél. : +33 (0)4 95 09 38 00 . Fax : +33 (0)4 95 09 38 01
Contacts : Julie Faber : julie.faber@mcocongres.com - Julia Schroeder : julia.schroeder@mcocongres.com
3
JOINT MEETING
15th ANNUAL PITTSBURGH VASCULAR SYMPOSIUM
MAY 24-26, 2018
19th SURGICAL AND RADIOLOGICAL ENDOVASCULAR SYMPOSIUM PITTSBURGH (PA)
EDITO
2000, 1ère édition du SRES.
18 ans après l’histoire nous a donné raison : force est de constater que les chirurgiens ont désormais
une orientation vers la radiologie interventionnelle et que les radiologues prennent en charge des
malades très chirurgicaux.
En 2018 nous continuerons dans cet esprit.
La deuxième réflexion se porte sur les échanges entre Américains et Français.
Nous avons eu la chance pendant 18 éditions d’être accompagnés de deux des représentants
américains les plus charismatiques, Michel Makaroun et Michael Dake - de leurs équipes et collègues.
Nous avons constitué avec le SRES une véritable communauté de pensée. Il nous semblait donc
logique, lorsqu’ils nous ont proposé une réunion commune entre nos deux meetings, le SRES et le
PVS, de répondre présents et d’honorer cette invitation.
Cette édition 2018 à Pittsburgh sera l’occasion de concrétiser cette démarche.
C’est également l’occasion pour les jeunes générations de prendre conscience de l’importance de
se confronter et de s’ouvrir au monde, d’échanger librement et sans frontières, et de rencontrer
de grands experts internationaux. Une tribune leur est offerte pour s’exprimer en anglais dans le
pays leader mondial de la pratique et de la recherche médicales.
De plus, Pittsburgh est une ville formidable - le fleuron de l’industrie, de l’économie, de l’art, et de
la médecine en Amérique du Nord.
L’esprit du SRES demeurera à Pittsburgh, et se poursuivra en 2019 à Ajaccio pour une 20e édition
de qualité.
Philippe Piquet
Jean-Michel Bartoli
SRES
4
FACULTY
LOCAL FACULTY Michael C. Madigan, MD INVITED FACULTY
Professor of Surgery
PITTSBURGH, PA Division of Vascular Surgery
UNITED STATES
Georges Al-Khoury, MD Michel S. Makaroun, MD Michael D. Dake, MD
Assistant Professor of Surgery Co-Director, UPMC Heart and Thelma and Henry Doelger
Division of Vascular Surgery Vascular Institute Professor (III)
Professor and Chair Department of Cardiothoracic
Efthymios Avgerinos, MD Division of Vascular Surgery Surgery
Associate Professor of Surgery Stanford University School of
Division of Vascular Surgery Kyle M. Markel, MD, RVT Medicine
Resident, Division of Vascular Falk Cardiovascular Research
Rabih A. Chaer, MD, MSc Surgery Center
Residency and Fellowship Stanford, CA
Program Director Dara Omer, MD
Professor of Surgery Fellow, Division of Interventional R. Clement Darling, III, MD
Division of Vascular Surgery Radiology President, Society for Vascular
Surgery
Raymond E. Eid, MD Ulka Sachdev, MD Professor of Surgery, Albany
Assistant Professor of Surgery Associate Professor of Surgery Medical College
Division of Vascular Surgery Division of Vascular Surgery Chief, Division of Vascular
Surgery, Albany Medical Center
Mohammad H. Eslami, MD Gregory Salzler, MD Hospital
Professor of Surgery Fellow, Division of Vascular Director, The Institute for
Division of Vascular Surgery Surgery Vascular Health and Disease
President, The Vascular Group
Elizabeth Genovese, MD Michael J. Singh, MD, FACS, RPVI Albany, NY
Chief Resident, Division of Associate Professor of Surgery
Vascular Surgery Division of Vascular Surgery Heather L. Gornik, MD, RVT, RPVI
Medical Director, Non Invasive
Eric S. Hager, MD Edith Tzeng, MD Vascular Laboratory
Assistant Professor of Surgery Professor of Surgery Cleveland Clinic Heart and
Division of Vascular Surgery Division of Vascular Surgery Vascular Institute
Cleveland, OH
Steven A. Leers, MD, RVT, RPVI, Sung Yang, MD
FSVU Fellow, Division of Vascular Laurel Hastings, MD
Medical Director, UPMC Vascular Surgery Chief Resident, Louisiana State
Laboratories University Health Sciences Center
Associate Professor of Surgery Theodore H. Yuo, MD, MSc New Orleans, LA
Division of Vascular Surgery Assistant Professor of Surgery
Division of Vascular Surgery Kim J. Hodgson, MD
Nathan Liang, MD Professor
Resident, Division of Vascular Department of Surgery
Surgery Chair, Division of Vascular Surgery
Southern Illinois University
Springfield, IL
5
JOINT MEETING
15th ANNUAL PITTSBURGH VASCULAR SYMPOSIUM
MAY 24-26, 2018
19th SURGICAL AND RADIOLOGICAL ENDOVASCULAR SYMPOSIUM PITTSBURGH (PA)
FACULTY
Barry T. Katzen, MD Darren Schneider, MD INVITED FACULTY
Clinical Professor of Radiology, Chief, Division of Vascular and
University of South Florida Endovascular Surgery
INTERNATIONAL
College of Medicine Weill Cornell Medicine
Jean-Noël Albertini
Associate Dean for Clinical New York Presbyterian Hospital
Cardiac and Vascular Surgery
Affairs, Florida International New York, NY
CHU St Etienne
University Herbert Wertheim
St. Etienne, France
College of Medicine Malachi Sheahan III, MD
Founder and Medical Director, Professor of Surgery
Charles Arteaga
Miami Cardiac & Vascular Program Director, Vascular
Radiodiagnosis and Medical
Institute Surgery Residency
Imaging
Miami, FL and Fellowship Programs
Hôpital d’instruction des armées
LSU Health Sciences Center
Sainte-Anne
Melissa L. Kirkwood, MD School of Medicine
Toulon, France
Associate Professor of Surgery Department of Surgery
Division of Vascular Surgery New Orleans, LA
Pierre-Antoine Barral
University of Texas
Radiology
Southwestern Medical Center Anton Sidawy, MD
Hôpital de la Timone
Dallas, TX Lewis B. Saltz Chair of Surgery
Marseille, France
Professor of Surgery
Emilia Krol, MD George Washington University
Jean-Michel Bartoli, MD
Fellow, Eastern Virginia Medical School of Medicine and Health
Radiology and Medical Imaging
School Sciences
Hôpital de la Timone
Norfolk, VA Washington, DC
Marseille, France
Jean M. Panneton, MD, FRCSC, Daniel Sze, MD, PhD
Wagih Ben Hassen
FACS Professor of Radiology
Radiology
Professor of Surgery Stanford University School of
Centre Hospitalier Sainte Anne
Chief & Program Director Medicine
Paris, France
Division of Vascular Surgery Stanford, CA
Eastern Virginia Medical School
Jean-Paul Beregi
Norfolk, VA Timothy Wu, MD, FACS
Radiology
Assistant Professor of Surgery
CHU Nîmes
Andre Ramdon, MBBS Division of Vascular Surgery
Nîmes, France
Fellow, Albany Medical College New Jersey Medical School
Albany, NY Rutgers, The State University of
Auréline Boitet
New Jersey
Vascular Surgery
Thomas Reifsnyder, MD, RVT Newark, NJ
Hôpital Henri Mondor
Director of Vascular Lab
Paris, France
Johns Hopkins Bayview Medical
Center
Iskander Bouassida
Baltimore, MD
Radiology
CHU Nîmes
Nîmes, France
6
FACULTY
Lionel Bourgeois Cédric Foussier Romaric Loffroy
Vascular Surgery Radiology Radiology and Diagnostic and
Hôpital de la Timone CHU Reims Therapeutic Medical Imaging
Marseille, France Reims, France CHU Dijon
Dijon, France
Louis Boyer Léonore Freycon
Radiology and Medical Imaging Vascular Surgery Jean Picquet
CHU Clermont-Ferrand CHU Montpellier Vascular Surgery
Clermont-Ferrand, France Montpellier, France CHU Angers
Angers, France
Xavier Chaufour Arnaud Gallon
Vascular Surgery Radiology Philippe Piquet, MD
CHU Rangueil CHU Clermont-Ferrand Vascular Surgery
Toulouse, France Clermont-Ferrand, France Hôpital de la Timone
Marseille, France
Laurent Chiche Marine Gaudry
Vascular Surgery Vascular Surgery Edouard Purenne
Hôpital Pitié Salpêtrière Hôpital de la Timone Radiology
Paris, France Marseille, France Hôpital Kremlin-Bicêtre
Paris, France
Philippe Cluzel Dominique Grisoli
Cardiovascular and Radiology Cardiothoracic Surgery Hervé Rousseau
Imaging Hôpital de la Timone Radiology and Medical Imaging
Hôpital Pitié-Salpêtrière Marseille, France Hôpital Rangueil
Paris, France Toulouse, France
Denis Herbreteau
Marc Coggia Diagnostic Neuroradiology and Fabien Thaveau
Vascular Surgery Interventional Vascular Surgery
Hôpital Ambroise Paré CHRU Tours Nouvel Hôpital Civil
Paris, France Tours, France Strasbourg, France
Thibault Couture Aurélien Hostalrich Farouk Tradi
Vascular Surgery Vascular Surgery Radiology
Hôpital Pitié Salpêtrière CHU Rangueil Hôpital de la Timone
Paris, France Toulouse, France Marseille, France
Mariangela De Masi Alexis Jacquier Hélène Vernhet-Kovacsik
Vascular Surgery Radiology and Medical Imaging Radiology and Medical Imaging
Hôpital de la Timone Hôpital de la Timone CHU Montpellier
Marseille, France Marseille, France Montpellier, France
Elsa Faure Hicham Kobeiter
Cardiac and Vascular Surgery Radiology and Medical Imaging
Hôpital Georges Pompidou Hôpital Henri Mondor
Paris, France Paris, France
7JOINT MEETING
15th ANNUAL PITTSBURGH VASCULAR SYMPOSIUM
MAY 24-26, 2018
19th SURGICAL AND RADIOLOGICAL ENDOVASCULAR SYMPOSIUM PITTSBURGH (PA)
THURSDAY, MAY 24, 2018
7:00 am
BREAKFAST & REGISTRATION
7:50 am
Welcome and Opening Remarks. Michel S. Makaroun
8:00-9:30am Scientific Session I: CAROTID / CEREBROVASCULAR
Moderators: Barry T. Katzen, Jean-Michel Bartoli, Philippe Piquet,
Edith Tzeng
8:00 am - Neurovascular Imaging: CTA, MRA or Duplex... All for one, one for all. Charles Arteaga
8:08 am - Update on the CREST-2 Trial: Will best medical therapy replace interventions
in asymptomatic disease? Barry T. Katzen
8:16 am - TCAR: A better approach to CAS or simply a better mouse trap to exclude non-
surgeons? Rabih A. Chaer
8:24 am - Mechanical thrombectomy for stroke management: How far can we go?
Wagih Ben Hassen
8:32 am - Can we modulate hypertension through the carotid bulb? Kim J. Hodgson
8:40 am - I am smarter after my CEA - Does carotid stenosis affect cognition?
Melissa L. Kirkwood
8:48 am - Discussion.
9:00 am - Cerebrovascular Case Presentation. French case
9:05 am - U.S. Fellow Analysis. Elizabeth Genovese
9:12 am - French Fellow Analysis. Cédric Foussier
9:19 am - Discussion and Voting by Moderators and Audience.
9:30-10:00 am BREAK & VISIT OF THE EXHIBITION
10:00-11:35 am
Scientific Session II: ABDOMINAL AORTIC
Moderators: R. Clement Darling III, Laurent Chiche, Darren Schneider
10:00 am - Digital simulation of aortic stent-grafts: Towards full computer assisted planning.
Jean-Noël Albertini
10:08 am - How is EVAR better than open repair for aortic ruptures despite 4 negative
randomized trials? R. Clement Darling III
10:16 am - Robotic surgery for the abdominal aorta: Young surgeons should pay attention.
Fabien Thaveau
10:24 am - Unusual surgical procedures for complex aortic lesions. Laurent Chiche
10:32 am - Internal Iliac artery preservation during EVAR: A welcome reality for an active
lifestyle. Darren Schneider
10:40 am - Laser in situ stent graft fenestration during complex EVAR.
Hicham Kobeiter, Pascal Desgranges
10:48 am - Discussion.
11:00 am - Aortic Case Presentation. U.S. case
11:05 am - French Fellow Analysis. Thibault Couture
11:12 am - U.S. Fellow Analysis. Andre Ramdon
11:19 am - Discussion and Voting by Moderators and Audience.
8THURSDAY, MAY 24, 2018
11:35 am EYE OPENER QUIZ: Fake News!
Jean-Michel Bartoli, Philippe Piquet, Michel S. Makaroun,
Michael D. Dake
Noon Groundbreaking clinical trials: Endovascular repair with a new
branch device (No CME credit awarded). Michael D. Dake
12:30-1:30 pm LUNCH & VISIT OF THE EXHIBITION
1:30-3:00 pm Scientific Session III: VENOUS THROMBOEMBOLISM
Moderators: Rabih A. Chaer, Daniel Sze, Mariangela De Masi
1:30 pm - Standard anticoagulation for acute and chronic venous thromboembolism.
Ulka Sachdev
1:38 pm - Venous stents: When to use them, techniques and how durable are they?
Michael J. Singh
1:46 pm - Are the results of the ATTRACT trial attractive and how will they change our
approach to acute DVT? Rabih A. Chaer
1:54 pm - Venous interventions we do now that we didn’t do 20 years ago. Daniel Sze
2:02 pm - Catheter interventions for acute pulmonary embolism. Efthymios Avgerinos
2:10 pm - Contemporary management of arteriovenous malformations. Denis Herbreteau
2:18 pm - Discussion.
2:30 pm - Venous Case Presentation. U.S. case
2:35 pm - French Fellow Analysis. Aurélien Hostalrich
2:42 pm - U.S. Fellow Analysis. Laurel Hastings
2:49 pm - Discussion and Voting by Moderators and Audience.
3:00-3:30 pm BREAK & VISIT OF THE EXHIBITION
3:30-5:00 pm Scientific Session IV: VISCERAL DISEASE / MISCELLANEOUS
Moderators: Michael J. Singh, Hélène Vernhet, Melissa L. Kirkwood
3:30 pm - Complex renal artery disease: My endovascular arsenal. Louis Boyer
3:38 pm - Non-atheromatous renal artery stenosis: Evaluation, treatment and follow up.
Hélène Vernhet
3:46 pm - Mesenteric ischemia: To stent or to bypass? Malachi Sheahan III
3:54 pm - Endovascular management of visceral aneurysms. Romaric Loffroy
4:02 pm - Risk management: The French paradox. Jean-Paul Beregi
4:10 pm - Radiation safety: Who should care and how to improve it? Melissa L. Kirkwood
4:18 pm - Discussion.
4:30 pm - Visceral Case Presentation. French case
4:35 pm - U.S. Fellow Analysis. Sung Yang
4:42 pm - French Fellow Analysis. Iskander Bouassida
4:49 pm - Discussion and Voting by Moderators and Audience.
5:00 pm Thursday Adjournment and Closing Remarks
Jean-Michel Bartoli, Philippe Piquet, Michel S. Makaroun,
Michael D. Dake
9JOINT MEETING
15th ANNUAL PITTSBURGH VASCULAR SYMPOSIUM
MAY 24-26, 2018
19th SURGICAL AND RADIOLOGICAL ENDOVASCULAR SYMPOSIUM PITTSBURGH (PA)
FRIDAY, MAY 25, 2018
7:00 am
BREAKFAST & REGISTRATION
7:50 am Welcome and Opening Remarks. Michel S. Makaroun
8:00-9:30am
Scientific Session V: PERIPHERAL VASCULAR DISEASE
Moderators: Kim J. Hodgson, Anton Sidawy, Xavier Chaufour
8:00 am - Is it time to have a certification program for vascular centers and in which
format would it be? Anton Sidawy
8:08 am - Developing a true CLI program: What does it involve? Barry T. Katzen
8:16 am - How to prevent popliteal stenting failures. Mariangela De Masi
8:24 am - Drug elution: A game changer or not? Kim J. Hodgson
8:32 am - Arterial stenting for PAD: When do I say NO! Philippe Cluzel
8:40 am - Aortoiliac disease: What is left for open reconstructions? Mohammad H. Eslami
8:48 am - Discussion.
9:00 am - PVD Case Presentation. French case
9:05 am - U.S. Fellow Analysis. Nathan Liang
9:12 am - French Fellow Analysis. Edouard Purenne
9:19 am - Discussion and Voting by Moderators and Audience.
9:30-10:00 am BREAK & VISIT OF THE EXHIBITION
10:00-11:35 am
Scientific Session VI: THORACOABDOMINAL AORTA
Moderators: Michael D. Dake, Dominique Grisoli, Michel S. Makaroun
10:00 am - Management of aortic dissection: The team and logistics.
Elsa Faure, Jean-Marc Alsac
10:08 am - Type B dissection: Is medical Rx still the best option? Hervé Rousseau
10:16 am - Preoperative evaluation of spinal cord perfusion. Pierre-Antoine Barral
10:24 am - Management of type A dissection: Setting the stage for future reinterventions.
Dominique Grisoli
10:32 am - Management of the false lumen after TEVAR. Michael D. Dake
10:40 am - Aortic remodeling after TEVAR for degenerative disease.
Philippe Piquet, Mariangela De Masi
10:48 am - Discussion.
11:00 am - Dissection Case Presentation. U.S. Case
11:05 am - French Fellow Analysis. Auréline Boitet
11:12 am - U.S. Fellow Analysis. Emilia Krol
11:19 am - Discussion and Voting by Moderators and Audience.
11:35 am SPECIAL LECTURE: The Fellowship of Vascular Specialists
Michael D. Dake
Noon Groundbreaking clinical trials: EndoAnchor implants in EVAR –
Mechanisms of action and clinical impact: New insights from the
ANCHOR Registry (No CME credit awarded). Jean M. Panneton
10FRIDAY, MAY 25, 2018
12:30-1:30 pm LUNCH & VISIT OF THE EXHIBITION
1:30-3:00 pm Scientific Session VII: MORE AORTIC TOPICS
Moderators: Darren Schneider, Hervé Rousseau, Jean M. Panneton
1:30 pm - Multimodal fusion: Immediate and long term benefits for TEVAR and FEVAR.
Alexis Jacquier
1:38 pm - Ascending aortic surgery under videoscopy. Marc Coggia
1:46 pm - Hybrid treatment for aortic arch lesions and indications for replacement of the
ascending aorta. Marine Gaudry
1:54 pm - Management of distal aortic arch disease. Xavier Chaufour
2:02 pm - Value and technique of endoanchors during TEVAR. Jean M. Panneton
2:10 pm - What is the best approach for descending thoracic aorta degenerative
aneurysm? Jean Picquet
2:18 pm - Discussion
2:30 pm - Aortic Case Presentation. French Case
2:35 pm - U.S. Fellow Analysis. Gregory Salzler
2:42 pm - French Fellow Analysis. Léonore Freycon
2:49 pm - Discussion and Voting by Moderators and Audience.
3:00-3:30 pm BREAK & VISIT OF THE EXHIBITION
3:30-5:00 pm Scientific Session VIII: EMBOLIZATION
Moderators: Daniel Sze, Romaric Loffroy
3:30 pm - Basics of embolization. Daniel Sze
3:38 pm - Role of fusion in prostatic embolization. Farouk Tradi, Vincent Vidal
3:46 pm - Emborrhoid: Treatment of hemorrhoids with arterial embolization.
Jean-Michel Bartoli
3:54 pm - Endoleak management with embolization: Trans-arterial, trans-lumbar,
trans-caval. Jean M. Panneton
4:02 pm - Endovascular embolization and stent grafts for trauma. Mohammad H. Eslami
4:10 pm - Liquid embolic agents: Applications and pipeline products. Daniel Sze
4:18 pm - Discussion.
4:30 pm - Embolization Case Presentation. U.S. case
4:35 pm - French Fellow Analysis. Arnaud Gallon
4:42 pm - U.S. Fellow Analysis. Dara Omer
4:49 pm - Discussion and Voting by Moderators and Audience.
5:00 pm Friday Adjournment and an Introduction to Baseball (in French)
Jean M. Panneton
11JOINT MEETING
15th ANNUAL PITTSBURGH VASCULAR SYMPOSIUM
MAY 24-26, 2018
19th SURGICAL AND RADIOLOGICAL ENDOVASCULAR SYMPOSIUM PITTSBURGH (PA)
SATURDAY, MAY 26, 2018
7:00 am
BREAKFAST & REGISTRATION
7:50 am Welcome and Opening Remarks. Eric S. Hager, Steven A. Leers
8:00-9:30am
Scientific Session IX: VENOUS INSUFFICIENCY / DIALYSIS ACCESS
Moderators: Eric S. Hager, Timothy Wu
8:00 am - When and how to ablate the perforators? Eric S. Hager
8:10 am - Ablation or foam for truncal insufficiency. Raymond E. Eid
8:20 am - Endovenous U.S.-guided laser therapy of venous dysplasia. Lionel Bourgeois
8:30 am - Reappraisal of the Fistula First Inititiative. Theodore H. Yuo
8:40 am - Novel grafts in dialysis access. Efthymios Avgerinos
8:50 am - Peritoneal dialysis. Eric S. Hager
9:00 am - Percutaneous arteriovenous fistula creation. Timothy Wu
9:10 am - Percutaneous techniques for AV access maintenance. Michael C. Madigan
9:20 am - Managing troublesome central venous occlusion. Timothy Wu
9:30-10:00 am BREAK
10:00-11:30 am
Scientific Session X: VASCULAR LABORATORY
Moderator: Steven A. Leers
10:00 am - RPVI Examination. Steven A. Leers
10:05 am - Basic transducer overview. Kyle M. Markel
10:20 am - Cerebrovascular diagnosis. Heather L. Gornik
10:30 am - Interesting carotid cases. Steve A. Leers
10:40 am - Physiologic arterial testing. Thomas Reifsnyder
10:50 am - Arterial duplex scanning. Heather L. Gornik
11:00 am - Arterial testing after intervention. Thomas Reifsnyder
11:10 am - Visceral scanning. Steven A. Leers
11:20 am - Duplex after EVAR. Kyle M. Markel
Noon Closing Remarks and Conference Adjournment
12PARTENAIRES
Le comité d’organisation souhaite remercier les partenaires de la 19ème édition du Surgical
and Radiological Endovascular Symposium pour leur soutien.
EDUCATIONAL GRANTS
Major Sponsors
Silver Sponsors
COOK MEDICAL
GETINGE-MAQUET
WL GORE & ASSOCIES
Bronze Sponsors
CORDIS
TERUMO
PARTENAIRES
CORDIS
EDWARDS LIFESCIENCES
GE HEALTHCARE
LEMAITRE VASCULAR
PEROUSE GROUPE VYGON
13NOTES
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
14NOTES
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
15S.M.A.R.T. CONTROL™
S.M.A.R.T.™ FLEX
FAMILLE DE STENTS
PREVISIBLE SOUS TOUS LES ANGLES
L’endoprothèse S.M.A.R.T. CONTROL™ est indiqué pour les patients présentant des artères périphériques athéroscléreuses, dont les artères iliaques et les artères fémorales superficielles, ainsi que
pour les procédures TIPSS™ et pour le traitement palliatif des néoplasmes cancéreux de l’arbre biliaire. L’endoprothèse vasculaire S.M.A.R.T.™ Flex est indiquée comme traitement pour les lésions
athérosclérotiques des artères fémorale superficielle, poplitée proximale ou dans les sténoses ou occlusions des artères iliaques externe et primitive. Avant toute utilisation, se référer à la notice
d’utilisation qui accompagne le dispositif et respecter les consignes d’utilisation y figurant et figurant sur l’étiquetage pour connaître les indications, les contre-indications, les effets secondaires,
l’utilisation recommandée, les mises en garde et les précautions. Dans un souci de constante amélioration de ses produits, Cordis se réserve le droit de modifier leurs caractéristiques sans préavis.
Dispositif médical de classe IIb (BSI 0086). Les endoprothèse SMART CONTROL et SMART FLEX sont inscrites sur la liste LPPR : code LPP 3171535. Mandataire européen Cordis Cashel (Irlande).
« Document réservé à l’usage des professionnels de santé ». Avril 2018. 100514138.
© 2018 Cardinal Health. Tous droits réservés. CORDIS, le LOGO Cordis, S.M.A.R.T. CONTROL et S.M.A.R.T. Flex sont des marques commerciales ou des marques déposées de Cardinal Health et peuvent
16être enregistrées aux Etats-Unis et / ou dans d’autres pays. CORDIS une division de CARDINAL HEALTH FRANCE 506 SAS, 43 rue Camille Desmoulins, 92130 Issy-les-Moulineaux. RCS Paris 812 365 609.Vous pouvez aussi lire
